Screening Of Prostate Specific Antigen (Psa) For The Detection Of Prostate Cancer And Its Prevalence In Jammu Region
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 7, Pages 3977-3985
AbstractProstate cancer is the most frequently detected non-cutaneous cancer in men. Prostate cancer is screened by using a biomarker that is prostate specific antigen and other prostate related problems. Not only the hereditary features are involved but also includes dietary factors, ecological factors also accountable for the progress of prostate cancer. Radical prostectomy is the most common therapy for small group of patients with high grade tumours. Early detection of PSA reduces the frequency rate of prostate cancer. Mostly prostate abnormalities are seen in among male patients above the age of 50 or older. In worldwide population the epidemiology of prostate cancer is high in western countries and less in Asian countries. In this project data was collected from the year Aug 2014 – April 2015. A total of 150 males had screened with PSA and out of total population 70 were found high level of PSA. Digital rectal examination and biopsy was performed on abnormal those patients sample whose PSA is raised. After examine their test I came to know that out of 70 samples 10 got prostate cancer. During the study period it was found that there will be 15-16% (1 year) hike in prostate cancer cases in Jammu district.
- Article View: 69
- PDF Download: 129